By Dan Nardi, CEO of Reimagine Care
At Reimagine Care, we’ve seen firsthand that cancer care operates in a class of its own. It moves faster, carries higher stakes and relies on a level of coordination that few other areas of medicine can match. From the moment a diagnosis is made, every patient interaction – every lab, call, symptom and side effect – carries weight. The technology that supports this journey can’t simply be repurposed from another specialty; it has to be reimagined for the realities of oncology.
Over the past few years, some in digital health have tried to extend their platforms from cardiology, diabetes or other specialties to also support oncology. On paper, it seems logical – if you can manage chronic disease remotely, why not cancer? But in practice, cancer care resists simplification. A typical patient may see multiple oncologists, undergo complex combination therapies and experience unpredictable side effects that demand immediate, specialized intervention. The workflows, data requirements and clinical guardrails are exponentially more intricate than those for most chronic conditions.
Complexity is the baseline.
Cancer treatment is inherently multidisciplinary, spanning medical, radiation and surgical oncology; pharmacy; nursing; palliative care; caregiver coordination; and psychosocial and financial support. A single missed symptom report can trigger a cascade of complications, from unplanned ER visits to treatment delays. Unlike standard remote monitoring, oncology requires real-time decision logic informed by lab results, biomarkers, regimen-specific toxicity profiles and pathway-based triage. Generic platforms aren’t designed for that kind of nuance, and adding an oncology tab won’t make them so.
Symptom monitoring isn’t a “nice-to-have.” It’s the intervention.
Studies have shown that structured, remote symptom reporting in oncology doesn’t just improve satisfaction – it can extend survival. But the success of that model depends on context. In oncology, a fever after chemotherapy means something different than a fever in diabetes or heart failure. A platform must interpret not only the symptom but also the regimen, the timing, and the patient’s treatment plan – then trigger the right escalation instantly. That’s not something that can be bolted on. It requires infrastructure built for the rhythms and risks of cancer care.
Oncology’s human layer is non-negotiable.
Patients navigating cancer face emotional, financial and logistical hurdles that intertwine with clinical needs. Financial toxicity, transportation barriers and treatment side effects aren’t separate issues. Instead they shape adherence, outcomes and even survival. Digital systems that treat these as “adjacent” functions miss the point. Oncology demands platforms that integrate care navigation, social support and clinical oversight into one continuous experience.
Home-enabled cancer care is possible, but only when designed for oncology.
We’ve learned that patients can safely receive portions of their care at home, but doing so requires oncology-specific protocols, 24/7 access to cancer-trained clinicians, and tight feedback loops with the primary oncology team. A general telehealth or hospital-at-home platform might connect a patient to a provider; an oncology platform connects them to their care team, their regimen, and their next best step.
So while digital transformation has improved outcomes in many specialties, oncology can’t simply be “added on” to existing platforms. The same system (tech + clinical support) that helps manage blood pressure or glucose levels won’t hold up under the complexity of chemotherapy, radiation or immunotherapy. Cancer care isn’t episodic, it’s continuous; it isn’t predictable, it’s adaptive.
At Reimagine Care, we’re building around that truth. We partner with oncology practices and health systems to create hybrid, tech-enabled care models that extend the reach of oncologists, improve patient experience, and reduce avoidable utilization – all while preserving the trust and continuity that define great cancer care.
Because oncology needs a digital solution that understands what’s at stake.